Andreas Busch
2021
In 2021, Andreas Busch earned a total compensation of $782.5K as Chief Scientific Officer at Cyclerion Therapeutics, a 3% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $135,922 |
|---|---|
| Option Awards | $113,183 |
| Salary | $492,320 |
| Other | $41,119 |
| Total | $782,544 |
Busch received $492.3K in salary, accounting for 63% of the total pay in 2021.
Busch also received $135.9K in non-equity incentive plan, $113.2K in option awards and $41.1K in other compensation.
Rankings
In 2021, Andreas Busch's compensation ranked 9,553rd out of 12,415 executives tracked by ExecPay. In other words, Busch earned more than 23.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,553 out of 12,415 | 23rd |
Division Manufacturing | 4,238 out of 5,508 | 23rd |
Major group Chemicals And Allied Products | 1,878 out of 2,378 | 21st |
Industry group Drugs | 1,666 out of 2,099 | 21st |
Industry Pharmaceutical Preparations | 1,241 out of 1,549 | 20th |
Source: SEC filing on April 26, 2022.
Busch's colleagues
We found two more compensation records of executives who worked with Andreas Busch at Cyclerion Therapeutics in 2021.